Latest European Society of Cardiology Stories
Too many major sports arenas in Europe do not have adequate equipment and procedures in place to save the lives of spectators who suffer heart attacks while watching a sporting event, according to new research published online today (Wednesday 3 March) in the European Heart Journal [1]. In a study of 187 top sports arenas in ten European countries, used by 190 elite soccer clubs, more than a quarter did not have automated external defibrillators on site and even more did not have medical...
"This study provides excellent ammunition both to convince patients about the benefits of reducing their individual salt intakes and also to persuade the EU of the urgent need to introduce legislation to restrict the salt content of processed foods," said ESC spokesman Professor Frank Ruschitzka, a cardiologist and hypertension specialist from the University of Zurich, Switzerland."This study represents the evidence that a reduction of salt intake not only lowers blood pressure...
Members of the European Parliament Heart Group (MEP HG) meet today, in Brussels, with the Cardiology profession and representatives of national Heart Foundations to evaluate the achievements at EU level in combating Cardiovascular Disease (CVD), and to reveal the need for further action.With the title 'Achieving Heart Health in Europe: Why the European Parliament Matters', the meeting is the first since the European elections in June this year. During the 2004-2009 term, the MEP Heart Group...
"The EU cannot turn its back on CVD", expressed Dirk Sterckx and Linda McAvan, both MEPs and co-chairs of the MEP Heart Group. There is overwhelming evidence that prevention and lifestyle modification brings about big health gains. It is therefore the task of decision makers at European and national level to ensure that effective policies supporting prevention are put in place.Indeed 80% of premature deaths can be prevented by tackling major risk factors particularly unhealthy diet and...
Body mass index (BMI) and waist circumference are well known risk factors for cardiovascular diseases (CVD), but a new study reported in the European Journal of Cardiovascular Prevention and Rehabilitation (a journal of the European Society of Cardiology) December 7 now concludes that these risk factors, when accurately measured by trained staff, can actually predict the risk of fatal and non-fatal disease.(1) The findings, which emerged from a large prospective study of more than 20,000...
The Second Pan Asian-Pacific ESC Symposium "“ Moving Towards a Global Approach to Cardiovascular Disease ManagementWith the rapidly increasing problem of cardiovascular (CVD) disease in Asia Pacific (AP), there is an urgency to raise awareness of risk factors. The European Society of Cardiology (ESC) is addressing the need to develop and adopt an integrated approach to CVD management, through important events organized in the region.CVD has become more prevalent in India and China than in...
The "˜Red Alert for Women's Hearts' conference, taking place on November 5, 2009, at the European Heart House, Sophia Antipolis, France, will address the subject of Women and Cardiovascular Disease (CVD). The conference is jointly organized by the European Society of Cardiology (ESC) and European Heart Network (EHN), as part of Work Package 6 of the EuroHeart project (1). Heart disease and stroke are the leading causes of death for women worldwide, killing more than 8.6 million, more than...
Learning the risks for stroke - and taking actionThe theme of this year's World Stroke Day on 29th October is "What can I do?". As the World Stroke Organization says, everyone can do something: learn to recognize symptoms and take action, learn to recognize the risk factors and take action. With this theme in mind, the European Society of Cardiology (ESC) emphasizes that most of the risks for stroke are also the major risks for coronary heart disease - and thus the object of the...
A study published in JAMA on October 21 by Nancy M. Albert and colleagues, exploring aldosterone antagonist usage among US patients hospitalized with heart failure, found that only one-third of patients meeting current US Clinical Practice Guidelines criteria were actually being treated (1).Furthermore, the observational analysis of 43,625 patients admitted with heart failure and discharged home from 241 hospitals participating in the "˜Get With IT Guidelines', showed that prescription of...
SCOTTSDALE, Ariz., Sept. 25 /PRNewswire/ -- MedPredict Market Research, a global provider of pharmaceutical competitive intelligence and market research, has published a new report providing critical strategic insight for companies marketing and developing anticoagulant therapies. This report is based on primary interviews conducted with cardiovascular experts from North America and Europe immediately following the European Society of Cardiology's 2009 annual meeting (ESC). "On the...
